gadoxetic-acid-disodium and Neuroblastoma

gadoxetic-acid-disodium has been researched along with Neuroblastoma* in 1 studies

Other Studies

1 other study(ies) available for gadoxetic-acid-disodium and Neuroblastoma

Article	Year
Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases. Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:2 A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia. Topics: Child; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroblastoma	2019

Article

Year

Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:2

A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia.

Topics: Child; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroblastoma

2019